Skolnick P, Weissman B A, Youdim M B
Br J Pharmacol. 1985 Nov;86(3):637-44. doi: 10.1111/j.1476-5381.1985.tb08940.x.
Buspirone, MJ-13805 and MJ-13653 did not produce a '5-hydroxytryptamine (5-HT) syndrome' in rats at doses up to 20 mg kg-1. These drugs were very weak 5-HT uptake blockers (IC50 much greater than 10 microM) compared to drugs such as chlorimipramine. These drugs did not inhibit either monoamine oxidase (MAO)-A or MAO-B. The Ki values for these agents as inhibitors of [3H]-5-HT and [3H]-ketanserin binding to rat frontal cortex or hippocampal membranes were in the microM range, well above the brain concentrations achieved after an oral dose of 25 mg kg-1. Parenterally administered buspirone blocked apomorphine-induced stereotypy, inhibited the 5-HT syndrome elicited by 5-methoxy-N,N-dimethyltryptamine, and delayed the onset of p-chloroamphetamine induced behaviours.
在大鼠中,给予高达20mg/kg的剂量时,丁螺环酮、MJ-13805和MJ-13653不会产生“5-羟色胺(5-HT)综合征”。与氯米帕明等药物相比,这些药物是非常弱的5-HT摄取阻滞剂(IC50远大于10μM)。这些药物既不抑制单胺氧化酶(MAO)-A也不抑制MAO-B。这些药物作为[3H]-5-HT和[3H]-酮色林与大鼠额叶皮质或海马膜结合的抑制剂,其Ki值在μM范围内,远高于口服25mg/kg剂量后达到的脑浓度。经胃肠外给药的丁螺环酮可阻断阿扑吗啡诱导的刻板行为,抑制5-甲氧基-N,N-二甲基色胺引发的5-HT综合征,并延迟对氯苯丙胺诱导行为的发作。